Circa Group AS

Circa Group AS Liabilities

Delisted

The The Liabilities of Circa Group AS (CIRCA.OL) as of Oct 23, 2026 is 6.89 M EUR. In the previous year, The Liabilities was 7.03 M EUR — a change of -2.03% (lower).

Liabilities

6.89 MEUR

YoY

-2.03%

Last updated:

In 2023, Circa Group AS's total liabilities amounted to 6.89 M EUR, a -2.03% difference from the 7.03 M EUR total liabilities in the previous year.

The Circa Group AS Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2020
6.89 M EUR
Jan 1, 2021
5.53 M EUR
Jan 1, 2022
7.03 M EUR
Jan 1, 2023
6.89 M EUR
The Circa Group AS Liabilities history
YEARLiabilitiesYoY
6.89 MEUR-2.03%
7.03 MEUR+27.32%
5.53 MEUR-19.76%
6.89 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Circa Group AS Stock analysis

What does Circa Group AS do? Circa Group AS produces biochemicals through its proprietary Furacell process, converting biomass into advanced bio-based chemicals. The company's product portfolio includes Cyrene, a bio-solvent derived from Levoglucosenone (LGO), which serves as a greener alternative to traditional toxic solvents in paints, coatings, battery, and textile applications. The company develops flavorings, biopolymers, and bio-solvents under development, with Cyrene being a key product for industrial processes requiring safer solvents. Subsidiaries such as Circa Sustainable Chemicals Pty Ltd, Circa Sustainable Chemicals SAS, Circa Sustainable Chemicals BV, and Circa Group Pty. Ltd. support the company's global operations. Circa Group AS sells its biochemical products primarily to industries requiring sustainable chemical solutions, including paint and coating manufacturers, battery producers, and textile companies. The company's focus on eco-friendly solvents like Cyrene targets markets seeking safer alternatives to conventional toxic solvents. By leveraging its Furacell process, Circa Group AS differentiates its offerings as advanced bio-based chemicals with improved environmental and performance profiles. The company's revenue streams are derived from the sale of its biochemical products, particularly Cyrene and other bio-solvents, to industrial clients across multiple sectors. Its subsidiaries facilitate regional market access and operational efficiency, supporting the commercialization of its proprietary technology. As a biotechnology firm, Circa Group AS monetizes its proprietary Furacell process by converting biomass into high-demand sustainable chemicals. Circa Group AS is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Circa Group AS's Liabilities

Circa Group AS's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Circa Group AS's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Circa Group AS's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Circa Group AS's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Circa Group AS’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Circa Group AS stock

The Liabilities of Circa Group AS is 6.89 M EUR in 2023.

The Liabilities of Circa Group AS changed from 7.03 M EUR to 6.89 M EUR, representing a -2.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Circa Group AS since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Circa Group AS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Circa Group AS

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Circa Group AS